Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated β-lactamase production and OmpK36 porin deficiency

Journal of Medical Microbiology

Volumn 58, Issue 9, 2009, Pages 1196-1202

  Xuan, Ding Wang ^a   Jia, Chang Cai ^a   Hong, Wei Zhou ^a   Zhang, Rong ^a   Chen, Gong Xiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE CTX M 14; BETA LACTAMASE DHA 1; BETA LACTAMASE TEM 1; CARBAPENEM DERIVATIVE; CEFEPIME; CEFMINOX; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; CLOXACILLIN; ERTAPENEM; GATIFLOXACIN; IMIPENEM; MEROPENEM; MYCOMYCIN; OUTER MEMBRANE PROTEIN; PANIPENEM; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN OMPK35; PROTEIN OMPK36; SULFONAMIDE; SULPERAZON; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CASE REPORT; CONTROLLED STUDY; DNA SEQUENCE; GENETIC ANALYSIS; HUMAN; KLEBSIELLA PNEUMONIAE; LUNG INFECTION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE EXPRESSION REGULATION, BACTERIAL; GENE TRANSFER, HORIZONTAL; HUMANS; KLEBSIELLA PNEUMONIAE; MOLECULAR SEQUENCE DATA; PLASMIDS; PORINS;

EID: 69049115140     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.008094-0     Document Type: Article

References (32)

1. Aktas, Z., Bal, C., Midilli, K., Poirel, L. & Nordmann, P. (2006). First IMP-1-producing Klebsiella pneumoniae isolate in Turkey. Clin Microbiol Infect 12, 695-696.
2. Albertí, S., Rodríquez-Quinoñes, F., Schirmer, T., Rummel, G., Tomás, J. M., Rosenbusch, J. P. & Benedí, V. J. (1995). A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding. Infect Immun 63, 903-910.
3. Bradford, P. A., Urban, C., Mariano, N., Projan, S. L., Rahal, J. J. & Bush, K. (1997). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 41, 563-569.
4. Cai, J. C., Zhou, H. W., Zhang, R. & Chen, G. X. (2008). Emergence of Serratia marcescens, Klebsiella pneumoniae and Escherichia coli possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 52, 2014-2018.
5. Cao, V. T., Arlet, G., Ericsson, B. M., Tammelin, A., Courvalin, P. & Lambert, T. (2000). Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother 46, 895-900.
6. CLSI (2006). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, approved standard M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute.
7. Crowley, B., Benedí, V. J. & Doménech- Sánchez, A. (2002). Expression of SHV-2 β-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob Agents Chemother 46, 3679-3682.
8. Doménech-Sánchez, A., Hernández-Allés, S., Martínez-Martínez, L., Benedí, V. J. & Albertí, S. (1999). Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in β-lactam antibiotic resistance. J Bacteriol 181, 2726-2732.
9. Doménech-Sánchez, A., Martínez-Martínez, L., Hernández-Allés, S., Conejo, M. C., Pascual, A., Tomás, J. M., Albertí, S. & Benedí, V. J. (2003). Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob Agents Chemother 47, 3332-3335.
10. Elliott, E., Brink, A. J., van Greune, J., Els, Z., Woodford, N., Turton, J., Warner, M. & Livermore, D. M. (2006). In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase. Clin Infect Dis 42, e95-e98.
11. Hernández-Allés, S., Albertí, S., Alvarez, D., Doménech-Sá nchez, A., Mart?́nez-Mart?́nez, L., Gil, J., Tomás, J. M. & Benedí, V. J. (1999). Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145, 673-679.
12. Jacoby, G. A., Mills, D. M. & Chow, N. (2004). Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae. Antimicrob Agents Chemother 48, 3203-3206.
13. ACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob Agents Chemother 50, 3396-3406.
14. Koh, T. H., Babini, G. S., Woodford, N., Sng, L. H., Hall, L. M. & Livermore, D. M. (1999). Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore. Lancet 353, 2162.
15. DHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 β-lactamases. J Antimicrob Chemother 60, 410-413.
16. Lee, K., Yong, D., Choi, Y. S., Yum, J. H., Kim, J. K., Woodford, N., Livermore, D. M. & Chong, Y. (2007b). Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss. Int J Antimicrob Agents 29, 201-206.
17. Lincopan, N., McCulloch, J. A., Reinert, C., Cassettari, V. C., Gales, A. C. & Mamizuka, E. M. (2005). First isolation of metallo-β- lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil. J Clin Microbiol 43, 516-519.
18. Macrina, F. L., Kopecko, D. J., Jones, K. R., Ayers, D. J. & McCowen, S. M. (1978). A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules. Plasmid 1, 417-420.
19. Martínez-Martínez, L., Hernández-Allés, S., Albertí, S., Tomás, J. M., Benedí, V. J. & Jacoby, G. A. (1996). In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob Agents Chemother 40, 342-348.
20. Mathew, A., Harris, A. M., Marshall, M. J. & Ross, G. W. (1975). The use of analytical isoelectric focusing for detection and identification of β-lactamase. J Gen Microbiol 88, 169-178.
21. Mena, A., Plasencia, V., García, L., Hidalgo, O., Ayestarán, J. I., Alberti, S., Borrell, N., Pérez, J. L. & Oliver, A. (2006). Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44, 2831-2837.
22. Rice, L. B., Carias, L. L., Etter, L. & Shlase, D. M. (1993). Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms. Antimicrob Agents Chemother 37, 1061-1064.
23. Smith Moland, E., Hanson, N. D., Herrera, V. L., Black, J. A., Lockhart, T. J., Hossain, A., Johnson, J. A., Goering, R. V. & Thomson, K. S. (2003). Plasmid mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother 51, 711-714.
24. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.
25. Wei, Z. Q., Du, X. X., Yu, Y. S., Shen, P., Chen, Y. G. & Li, L. J. (2007). Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 51, 763-765.
26. Woodford, N., Tierno, P. M., Young, K., Jr, Tysall, L., Palepou, M.-F. I., Ward, E., Painter, R. E., Suber, D. F., Shungu, D. & other authors (2004). Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 48, 4793-4799.
27. Yan, J. J., Ko, W. C., Tsai, S. H., Wu, H. M. & Wu, J. J. (2001). Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying blaIMP-8 in a university medical center in Taiwan. J Clin Microbiol 39, 4433-4439.
28. Yan, J. J., Ko, W. C., Jung, Y. C., Chuang, C. L. & Wu, J. J. (2002). Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. J Clin Microbiol 40, 3121-3126.
29. Yigit, H., Queenan, A. M., Anderson, G. J., Doménech- Sánchez, A., Biddle, J. W., Steward, C. D., Albert?́, S., Bush, K. & Tenover, F. C. (2001). Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45, 1151-1161.
30. Yu, Y., Ji, S., Chen, Y., Zhou, W., Wei, Z., Li, L. & Ma, Y. (2007). Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China. J Infect 54, 53-57.
31. Zhang, R., Zhou, H. W., Cai, J. C. & Chen, G. X. (2007). Plasmidmediated carbapenem-hydrolysing β-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother 59, 574-576.
32. Zhang, R., Yang, L., Cai, J. C., Zhou, H. W. & Chen, G. X. (2008). Highlevel carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol 57, 332-337.